Anticoagulation in MCS

Update: 2024-08-01

Description

With Hannah Schaubroeck, ICU, Ghent University Hospital - Belgium, and Christophe Vandenbriele, Harefield Hospital, Royal Brompton and Harefield NHS Foundation Trust, London - UK and OLV Hospital, Aalst - Belgium.

Challenges associated with the anticoagulation and hemostasis disorders during MCS.

Comments

In Channel

MCS complications - part 1

2025-09-1518:17

Differences in the management of acute MI in older people- one size does not fit everyone!

2025-07-2813:40

Ventilation in acute cardiac care (part I)

2025-07-0119:00

Acute valvular emergencies

2025-05-3014:47

When palliative care empowers intensive care

2025-03-2611:26

Catheter-directed therapies for acute pulmonary embolism

2025-02-2516:55

Spontaneous coronary artery dissection (SCAD), an emerging cause of acute coronary syndrome

2025-02-0616:07

Novel electrical therapies for patients with ADHF: a joint ACVC & EHRA Cardio Talk

2025-01-0616:39

Resuscitated cardiac arrest. What now?

2024-12-0214:08

Echocardiography in the MCS management

2024-11-0412:58

Anticoagulation in MCS

2024-08-0108:11

No more beta-blockers after AMI? The results of the REDUCE-AMI trial

2024-07-0513:08

What have we learned from the DanGer Shock trial?

2024-06-0312:38

Stress cardiomyopathies in the acute setting- what to do and what not to do

2024-03-1512:08

Optimal timing for percutaneous MCS in cardiogenic shock

2023-11-2811:18

Cardiac biomarkers in non-cardiac surgery

2023-10-2316:30

The use of diuretics in AHF

2023-09-0609:51

00:00

Anticoagulation in MCS

European Society of Cardiology

#box-pro-ellipsis-175920241008896{-webkit-line-clamp:2;}Anticoagulation in MCS

Anticoagulation in MCS

European Society of Cardiology

Anticoagulation in MCS